24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
100% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
95.12% |
|
ALZHEIMERS |
4.88% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
52.33% |
|
INFLUENZA |
8.46% |
|
ENZYME DYNAMICS |
7.93% |
|
CANCER |
7.54% |
|
ANTIBODY DYNAMICS SIMULATION |
6.16% |
|
RCA OLIGOMER STABILITY SIMULATIONS |
4.52% |
|
RCA STABILITY SIMULATIONS |
2.66% |
|
RCA OLIGOMERIC STABILITY MD SIMULATIONS |
2.31% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
1.67% |
|
MEMBRANE TRANSPORT |
1.51% |
|
RCA OLIGOMER STABILITY MD SIMULATIONS HEAT STRESS |
1.26% |
|
NIPAH VIRUS DECOY PROTEIN DYNAMICS |
1.25% |
|
RCA OLIGOMERIC STABILITY TEMPERATURE SIMULATION |
.8% |
|
NIPAH VIRUS DECOY PROTEIN DESIGN |
.57% |
|
RCA STABILITY TEMPERATURE SIMULATIONS |
.43% |
|
RCA OLIGOMERIC STABILITY HEAT STRESS SIMULATIONS |
.37% |
|
SUCROSE TRANSPORTER ATSUC1 |
.26% |